University of Kansas Cancer Center
You are here
Location Info
University of Kansas Cancer Center
Division of Hematologic Malignancies and Cellular Therapeutics
Division of Hematologic Malignancies and Cellular Therapeutics
4000 Cambridge St.,
Kansas City, KS 66160
Kansas City, KS 66160
Phone number: (913) 588-9187
Background data
Program type: Adult Program
FACT Approved: Yes
Year CAR T-cell Therapy Program Opened: 2015
CAR T-cell therapies performed
Year | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Number Performed | 39 | 57 | 90 | 116 |
Program Director
Name | Phone |
---|---|
Mia Strusz, MSHA | (913) 588-6030 |
Medical Director
Name | Phone |
---|---|
Joseph McGuirk, DO | (913) 588-6030 |
Physician
Name | Phone |
---|---|
Haitham Abdelhakim, MD | (913) 588-6030 |
Sunil Abhyankar, MD | (913) 588-6030 |
Nausheen Ahmed, MD | (913) 588-6030 |
Rajat Bansal, MD | (913) 588-6030 |
Forat Lutfi, MD | (913) 588-6030 |
Joseph McGuirk, DO | (913) 588-6030 |
Leyla Shune, MD | (913) 588-6030 |
Anurag Singh, MD | (913) 588-6030 |
Muhammad Umair Mushtaq, MD | (913) 588-6030 |
Coordinator
Name | Phone |
---|---|
Allison Appenfeller, RN, BSN, OCN | (913) 588-9821 |
Sarah Bromert, RN, BSN | (913) 588-9821 |
Social Worker
Name | Phone |
---|---|
Cristina Hernandez, LSCSW | (913) 908-9583 |
Jennifer McCabe, LSCSW | (913) 218-4936 |
Jessica Russell, LMSW, CCM | (913) 945-9401 |
Sarah Stevens, LMSW | (913) 484-5931 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)